Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

TEVA - Teva Pharmaceutical Industries... | Finranks

Home

/

TEVA

T

Teva Pharmaceutical Industries Limited (TEVA)

NYQ – Real Time Price. Currency in USD

37.14

+0.66 (1.81%)

Market open: Aug 12, 2026, 10:18 AM EDT

36.51

+0.03 (0.08%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

17.46B

16.59B

15.81B

14.86B

Cost of goods sold

-8.39B

-8.52B

-8.18B

-7.92B

Gross Profit

9.07B

8.07B

7.63B

6.93B

Operating expenses (excl. COGS)

-5.03B

-4.72B

-4.44B

-4.27B

Operating Income

4.05B

3.34B

3.19B

2.67B

Non-operating income, total

-2.82B

-4.63B

-3.81B

-5.82B

Pretax income

1.23B

-1.29B

-622M

-3.15B

Equity in earnings

15M

1M

2M

21M

Taxes

181M

-679M

7M

640M

Non-controlling/minority interest

-8M

322M

56M

53M

After tax other income/expense

0

0

0

0

Net income before discontinued operations

1.42B

-1.65B

-558M

-2.44B

Discontinued operations

0

0

0

0

Net income

1.42B

-1.65B

-558M

-2.44B

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

40.75B+3.6%

39.33B-9.6%

43.48B-1.2%

44.01B

Total current assets

13.95B

12.55B

12.49B

12.05B

Total non-current assets

26.80B

26.77B

30.99B

31.96B

Total liabilities

32.83B-2.3%

33.61B-4.9%

35.35B-0.2%

35.41B

Total current liabilities

13.46B

12.80B

12.25B

11.47B

Total non-current liabilities

19.38B

20.81B

23.11B

23.95B

Total equity

7.91B

5.72B

8.13B

8.60B

Total liabilities & shareholders' equities

40.75B

39.33B

43.48B

44.01B

Total debt

17.23B-5.3%

18.18B-10.3%

20.27B-6.4%

21.65B

Name

2025

2024

2023

2022

Cash from operating activities

2.89B

2.55B

2.84B

2.72B

Cash from investing activities

-519M

-566M

-508M

-482M

Cash from financing activities

-2.13B

-1.74B

-1.91B

-1.48B

Free cash flow

2.38B+16.2%

2.05B-11.4%

2.31B+6.4%

2.17B